COLUMBUS 7-year update: a randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanomaDirk Schadendorf,Reinhard Dummer,Keith T. Flaherty,Caroline Robert,Ana Arance,Jan Willem B. de Groot,Claus Garbe,Helen J. Gogas,Ralf Gutzmer,Ivana Krajsová,Gabriella Liszkay,Carmen Loquai,Mario Mandalà,Naoya Yamazaki,Paola Queirolo, Carolin Guenzel,Anna Polli, Mahgull Thakur,Alessandra di Pietro,Paolo A. AsciertoEuropean Journal of Cancer(2024)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要